#iptacopan — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #iptacopan, aggregated by home.social.
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505